Author Guidelines

Indus Journal of Medical and Health Sciences (IJMHS)

Print ISSN: 2960-2777
Online ISSN: 2960-2785
Publisher: Indus Education and Research Network SMC-Private Limited
Publication Frequency: Biannual
Language: English
Journal Website: https://induspublishers.com/index.php/IJMHS

1. Introduction

The Indus Journal of Medical and Health Sciences (IJMHS) is a peer-reviewed, open-access scientific journal dedicated to publishing original, scientifically rigorous, and ethically conducted research across medicine, clinical practice, public health, and allied health sciences.

IJMHS welcomes submissions from researchers, clinicians, healthcare professionals, academics, and institutions worldwide. The journal is committed to advancing medical knowledge, supporting evidence-based healthcare, and promoting the responsible dissemination of scientific findings.

Authors are encouraged to prepare manuscripts in accordance with the recommendations of the International Committee of Medical Journal Editors (ICMJE), the ethical principles promoted by the Committee on Publication Ethics (COPE), and relevant reporting standards provided by the EQUATOR Network.

All manuscripts must comply with the journal's publication ethics, research integrity, editorial, and submission requirements.

2. Aims and Scope

IJMHS considers scholarly contributions covering a broad range of medical and healthcare disciplines, including:

  • Clinical medicine and medical specialties

  • Surgery and surgical sciences

  • Public health and epidemiology

  • Pharmacology and pharmaceutical sciences

  • Medical microbiology and infectious diseases

  • Pathology and laboratory medicine

  • Nursing and allied health sciences

  • Dentistry and oral health

  • Maternal, neonatal, and child health

  • Healthcare management and health systems

  • Medical education and professional development

  • Biomedical research and diagnostic technologies

  • Preventive medicine and community health

  • Medical ethics and health policy

  • Rehabilitation and physiotherapy

  • Mental health and behavioral medicine

  • Emerging healthcare technologies and digital health

Interdisciplinary studies that contribute to medical knowledge, clinical improvement, or healthcare policy are encouraged.

3. Categories of Manuscripts

IJMHS welcomes the following manuscript categories. Authors should select the most appropriate article type before submission.

Article Type Suggested Word Limit Abstract References
Original Research Article 4,000–5,000 250–300 words Up to 50
Review Article 5,000–6,000 250–300 words Up to 100
Systematic Review and Meta-analysis 5,000–6,000 250–300 words As required
Case Report 1,500–2,500 Up to 200 words Up to 25
Short Communication 2,000–3,000 Up to 200 words Up to 30
Editorial 1,000–1,500 Optional Up to 20
Letter to the Editor 500–1,000 Not required Up to 10

Word counts exclude the title page, abstract, references, tables, and figure legends unless otherwise specified.

The editorial office may consider manuscripts exceeding these limits where scientifically justified.

4. General Manuscript Preparation

Manuscripts should be written in clear, grammatically correct, and scientifically appropriate English.

The following formatting requirements are recommended:

  • File format: Microsoft Word (.doc or .docx), OpenDocument, or RTF.

  • Font: Times New Roman, 12-point.

  • Line spacing: Single spacing, consistent with the journal's online submission checklist.

  • Page layout: A4 paper with standard margins.

  • Page numbering: Continuous throughout the manuscript.

  • Headings: Clearly structured and consistently formatted.

  • Abbreviations: Define at first mention unless internationally recognized.

  • Units: Use the International System of Units (SI) wherever applicable.

  • Tables and figures: Number consecutively and place near their first citation in the text.

  • References: Follow the Vancouver numerical referencing style.

  • Language: Use clear scientific terminology and avoid unnecessary repetition.

Authors should ensure that the manuscript is carefully proofread before submission.

5. Structure of Original Research Articles

Original research manuscripts should ordinarily follow the IMRaD structure.

5.1 Title Page

The title page must include:

  1. Full manuscript title.

  2. Short running title, preferably no more than 50 characters.

  3. Full names of all authors.

  4. Institutional affiliations of each author, including department, institution, city, and country.

  5. ORCID iDs, where available.

  6. Corresponding author's name, institutional address, and email address.

  7. Author contributions.

  8. Funding information.

  9. Conflict of interest declaration.

The manuscript title should accurately represent the study without exaggerated or unsupported claims.

5.2 Abstract

Original research articles should include a structured abstract of approximately 250–300 words with the following headings:

Background: Briefly introduce the scientific problem and its significance.

Objective: State the primary aim or research question.

Methods: Summarize the research design, setting, participants, procedures, and statistical methods.

Results: Present the principal findings, including relevant numerical results.

Conclusion: Explain the main interpretation and implications of the findings without overstating the evidence.

The abstract should accurately reflect the content of the manuscript and should not contain citations.

5.3 Keywords

Provide 3–6 keywords immediately after the abstract.

Authors are encouraged to use recognized terms from the National Library of Medicine's Medical Subject Headings (MeSH) vocabulary.

5.4 Introduction

The introduction should establish the scientific background, identify the knowledge gap, and explain the rationale for conducting the study.

The section should conclude with a clearly defined research objective or hypothesis.

5.5 Materials and Methods

Authors must provide sufficient methodological information to allow independent evaluation and, where appropriate, replication of their research.

This section should describe:

  • Study design and setting.

  • Study duration.

  • Study population and eligibility criteria.

  • Sampling methodology and sample size determination.

  • Data collection procedures.

  • Instruments and measurement methods.

  • Primary and secondary outcomes.

  • Ethical approval and informed consent.

  • Statistical analysis procedures.

  • Statistical software and version used, where applicable.

The ethical review committee's name, approval reference number, and approval date should be reported when applicable.

Any substantial departures from the approved study protocol should be explained.

5.6 Results

Results must be presented clearly, accurately, and objectively.

Authors should report relevant descriptive and inferential statistics, including effect estimates, confidence intervals, and exact p-values where appropriate.

Results should correspond to the objectives and methodological procedures described in the manuscript.

Data presented in tables should not be unnecessarily repeated in the text.

5.7 Discussion

The discussion should interpret the study findings in relation to existing scientific evidence.

Authors should:

  • Explain the principal findings.

  • Compare results with previously published studies.

  • Discuss plausible scientific or clinical explanations.

  • Identify strengths and limitations.

  • Explain implications for healthcare practice, research, or policy.

  • Suggest areas requiring further investigation.

Unsupported claims, unnecessary repetition, and conclusions extending beyond the evidence should be avoided.

5.8 Conclusion

The conclusion should summarize the main findings and their scientific or clinical significance.

Conclusions must remain consistent with the study design, methods, and results.

6. Review Articles and Systematic Reviews

Narrative review articles should provide a balanced and critical evaluation of current scientific knowledge on a clearly defined topic.

Systematic reviews and meta-analyses must describe their literature search methods, eligibility criteria, study selection, data extraction, quality assessment, and synthesis procedures.

Authors should follow the PRISMA 2020 reporting guideline, where applicable.

Systematic reviews should provide registration details, such as a PROSPERO registration number, when available.

The absence of registration must not be misrepresented.

7. Case Reports

Case reports should describe clinically significant, unusual, or educational patient presentations that contribute meaningfully to medical knowledge.

Authors are encouraged to follow the CARE reporting guidelines.

A case report should ordinarily include:

  • Introduction

  • Case presentation

  • Clinical findings

  • Diagnostic assessment

  • Therapeutic intervention

  • Follow-up and outcomes

  • Discussion

  • Conclusion

  • Patient consent statement

Written informed consent for publication must be obtained from the patient or an authorized representative, as applicable, particularly when potentially identifiable clinical information or images are included.

Patient privacy and confidentiality must be protected.

8. Research Ethics and Ethical Approval

IJMHS expects all research to meet internationally recognized ethical standards.

8.1 Human Participant Research

Research involving human participants, patient records, biological specimens, or identifiable health information must comply with applicable institutional and national requirements.

Ethical approval or a documented exemption must be obtained from an appropriately constituted ethics review committee when required.

Authors must provide an ethics statement identifying:

  • Name of the approving ethics committee.

  • Ethics approval number, where issued.

  • Date of approval.

  • Informed consent status or approved waiver, where applicable.

Human research should be conducted in accordance with relevant ethical principles, including the Declaration of Helsinki.

8.2 Animal Research

Studies involving animals must follow applicable institutional, national, and internationally accepted animal welfare standards.

Authors must report approval from the relevant animal ethics committee, where required, and provide details of procedures intended to minimize animal suffering.

The ARRIVE guidelines should be followed for relevant animal research.

8.3 Clinical Trial Registration

Clinical trials must be prospectively registered in an appropriate publicly accessible trial registry consistent with ICMJE recommendations.

The registry name and registration number must be provided in the manuscript.

Authors must disclose discrepancies between the registered protocol and reported outcomes.

9. Reporting Guidelines

Authors should follow the reporting guideline appropriate to their study design.

Study Design Reporting Guideline
Randomized Controlled Trials CONSORT
Observational Studies STROBE
Systematic Reviews and Meta-analyses PRISMA
Diagnostic Accuracy Studies STARD
Case Reports CARE
Qualitative Research COREQ or SRQR
Animal Research ARRIVE
Quality Improvement Studies SQUIRE
Study Protocols SPIRIT or appropriate protocol guidance

Relevant checklists and flow diagrams should accompany manuscripts when required by the applicable guideline.

Additional information is available from the EQUATOR Network at https://www.equator-network.org.

10. Authorship and Author Contributions

Authorship should be assigned according to the ICMJE recommendations.

Each author should satisfy all four authorship criteria:

  1. Make a substantial contribution to the conception or design of the study, or acquisition, analysis, or interpretation of data.

  2. Participate in drafting the manuscript or critically revising it for important intellectual content.

  3. Approve the final version for publication.

  4. Agree to be accountable for the integrity and accuracy of the work.

Individuals who do not meet authorship criteria should be acknowledged appropriately, with their permission.

The corresponding author is responsible for ensuring that all authors approve the submission and that authorship information is accurate.

Any proposed change to authorship after submission must be explained and supported by written agreement from all relevant authors.

11. Originality, Plagiarism, and Duplicate Publication

IJMHS considers manuscripts submitted as original scholarly contributions.

By submitting a manuscript, authors confirm that:

  • The work has not been published previously in a manner constituting duplicate publication.

  • The manuscript is not simultaneously under consideration by another journal.

  • All sources have been appropriately acknowledged.

  • Data and results have not been fabricated or falsified.

  • Figures and images have not been inappropriately manipulated.

  • Reused materials have the necessary permissions.

  • Any related manuscripts, preprints, or overlapping publications have been disclosed.

Manuscripts may be screened using plagiarism detection software.

Suspected plagiarism, redundant publication, image manipulation, citation manipulation, or other research misconduct will be evaluated according to the journal's published ethical policies and relevant COPE guidance.

Manuscripts containing substantiated serious ethical violations may be rejected. Post-publication concerns may result in corrections, expressions of concern, or retractions, as appropriate.

12. References and Citation Style

IJMHS recommends the Vancouver referencing style, consistent with established biomedical publishing conventions.

References should be numbered consecutively according to their first appearance in the manuscript.

Citations should appear as numerical references in the text, such as [1], [2], or [3–5].

Authors are responsible for ensuring that all references are complete, accurate, relevant, and traceable.

Where available, provide the DOI in a standard URL format.

Example: Journal Article

Author AA, Author BB, Author CC. Title of the article. Journal Title. 2025;12(2):115-123. https://doi.org/xxxxx

Example: Book

Author AA. Title of the Book. 3rd ed. Publisher; 2024.

Example: Website

Organization Name. Title of the Webpage. Available from: https://www.example.org. Accessed November 21, 2026.

These are formatting illustrations, not actual bibliographic references.

Authors should prioritize relevant primary literature and avoid excessive self-citation or references included solely to influence citation metrics.

13. Tables, Figures, and Illustrations

Tables and figures must provide accurate, relevant, and clearly presented scientific information.

Tables

  • Number tables consecutively using Arabic numerals.

  • Provide a descriptive title above each table.

  • Explain abbreviations and statistical symbols in footnotes.

  • Avoid unnecessary duplication of information.

  • Ensure values correspond with the manuscript text.

Figures

  • Number figures consecutively.

  • Provide informative figure legends.

  • Submit clear, high-quality images suitable for publication.

  • Use sufficient resolution for scientific interpretation; approximately 300 dpi for photographic images is recommended.

  • Identify any adjustments made to images when relevant.

  • Obtain permission for copyrighted materials.

Clinical photographs must not reveal patient identities unless publication consent explicitly permits identifiable images.

Image enhancement must not alter or misrepresent scientific findings.

14. Statistical Reporting

Statistical methods must be appropriate to the research design and clearly explained.

Authors should report:

  • Sample size and its justification.

  • Statistical tests employed.

  • Measures of central tendency and variability.

  • Effect sizes and confidence intervals, where applicable.

  • Exact p-values where practical.

  • Handling of missing data.

  • Adjustments for multiple comparisons where relevant.

  • Statistical software used.

Authors should not interpret statistical significance as equivalent to clinical importance.

Where appropriate, analysis plans and additional statistical documentation may be requested during editorial assessment.

15. Data Availability and Research Transparency

IJMHS encourages authors to promote transparency and reproducibility.

Research manuscripts should include a data availability statement explaining whether the supporting data can be accessed and under what conditions.

Where legal, ethical, and confidentiality requirements permit, authors are encouraged to deposit relevant datasets in recognized repositories.

For restricted data, the statement should explain why public release is not possible.

Authors should retain original research records and be prepared to provide supporting documentation to the editorial office when reasonably required.

16. Conflicts of Interest and Funding

All authors must disclose relationships or circumstances that could reasonably be perceived as influencing their work.

These may include financial relationships, employment, consultancy arrangements, research sponsorship, intellectual property interests, or relevant personal and professional relationships.

A declaration should be included even when no competing interests exist.

Suggested declaration:

"The authors declare that they have no competing interests."

All financial support must be acknowledged, including grant numbers when available.

Authors must identify the funder's role in study design, data collection, analysis, interpretation, manuscript preparation, and publication decisions, where applicable.

17. Artificial Intelligence and AI-Assisted Tools

Authors must transparently disclose any substantive use of generative artificial intelligence or AI-assisted tools in manuscript preparation, data processing, analysis, or the generation of figures.

AI tools must not be listed as authors because they cannot accept responsibility for published scientific work.

Authors remain fully accountable for the accuracy, originality, integrity, confidentiality, and appropriate attribution of all submitted content.

AI-generated references, fabricated datasets, or manipulated research findings are unacceptable.

When AI tools have been used, authors should identify the tool and explain its purpose in the appropriate manuscript section.

Routine spelling and grammar assistance need not be treated as substantive scientific contributions, although transparency is encouraged.

18. Peer Review and Editorial Evaluation

All submitted manuscripts undergo an initial editorial assessment to determine their suitability for IJMHS.

During this stage, manuscripts may be evaluated for:

  • Relevance to the journal's aims and scope.

  • Scientific originality and significance.

  • Methodological quality.

  • Research ethics and integrity.

  • Compliance with author guidelines.

  • Completeness of required documentation.

  • Clarity of scientific presentation.

Manuscripts considered suitable for further evaluation are referred for independent expert peer review according to the journal's established peer-review policy.

Reviewer recommendations may result in acceptance, a request for revision, further review, or rejection.

The final decision regarding publication rests with the journal's authorized editorial decision-maker.

Editorial decisions must be based on scientific quality, ethical compliance, relevance, and the validity of the research rather than the authors' nationality, institutional affiliation, or financial status.

19. Manuscript Revision

Authors invited to revise a manuscript should carefully address all editorial and reviewer comments.

The revised submission should include:

  1. A revised manuscript.

  2. A detailed point-by-point response to reviewer comments.

  3. A marked version showing changes, when requested.

  4. Updated ethical or supporting documentation, where applicable.

Authors should explain respectfully and scientifically when they disagree with a reviewer recommendation.

Submission of a revised manuscript does not guarantee acceptance.

20. Article Processing Charges

IJMHS operates as an open-access journal.

The journal's published Article Processing Charge is:

USD 50 per accepted article.

Article processing charges support publication-related services, including editorial processing, manuscript preparation, typesetting, and online hosting.

Payment of an article processing charge does not guarantee acceptance.

Editorial decisions must remain independent of payment considerations.

Any applicable waivers or discounts are governed by the journal's published waiver policy.

Authors are advised to consult the current fee policy before submission.

21. Copyright and Open Access Licensing

Authors retain the copyright of their published work.

Articles are published under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (CC BY-NC-SA 4.0).

This license permits non-commercial sharing and adaptation with appropriate attribution and requires adapted material to be distributed under the same license.

Commercial use requires permission from the relevant copyright holder.

Published articles remain openly accessible to readers without subscription barriers.

Full licensing terms are available at:

https://creativecommons.org/licenses/by-nc-sa/4.0/

22. Corrections, Retractions, and Research Integrity

IJMHS is committed to maintaining the integrity of the scholarly record.

Where necessary, the editorial office may investigate concerns relating to published articles, including significant errors, plagiarism, data fabrication, unethical research, or other misconduct.

Appropriate editorial actions may include:

  • Publication of corrections.

  • Publication of expressions of concern.

  • Retraction of articles.

  • Notification of relevant institutions or authorities where justified.

Such actions will be considered in accordance with the journal's published policies and relevant COPE guidance.

23. Manuscript Withdrawal

Authors who wish to withdraw a submitted manuscript must provide a written request explaining the reason for withdrawal.

According to the journal's published fee policy, no withdrawal fee is charged before formal acceptance.

A withdrawal fee may apply to requests made after acceptance, subject to the journal's applicable policies.

Authors should communicate promptly with the editorial office when withdrawal becomes necessary.

24. Submission Procedure

All manuscripts should be submitted through the journal's online submission system.

Online Submission Portal:
https://induspublishers.com/index.php/IJMHS/about/submissions

Authors should follow these steps:

  1. Register or log in to the journal's submission system.

  2. Start a new submission.

  3. Select the appropriate manuscript category.

  4. Confirm compliance with the submission checklist.

  5. Upload the manuscript and applicable supplementary documents.

  6. Enter complete manuscript metadata, including author details, title, abstract, and keywords.

  7. Review all information and complete the submission.

Authors should ensure that the submission metadata agrees with the manuscript files.

Required Submission Documents

The following documents should be prepared as applicable:

  • Main manuscript file.

  • Title page containing author information.

  • Cover letter.

  • Ethical approval documentation or explanation of exemption.

  • Informed consent or publication consent documentation, where relevant.

  • Conflict of interest and funding declarations.

  • Relevant reporting guideline checklist.

  • Supplementary datasets, figures, or supporting documents.

The cover letter should briefly explain the manuscript's originality, scientific contribution, relevance to IJMHS, and confirmation that the work is not being simultaneously considered elsewhere.

25. Final Submission Checklist

Before submitting a manuscript, authors should confirm that:

  • The manuscript falls within the journal's aims and scope.

  • All authors have reviewed and approved the submission.

  • The work is original and is not simultaneously submitted elsewhere.

  • The title, abstract, keywords, and manuscript structure are complete.

  • Ethical approval and informed consent statements are included where applicable.

  • Authorship, funding, and competing interest declarations are provided.

  • References are accurate and consistently formatted.

  • Tables and figures are numbered and cited correctly.

  • Relevant reporting guidelines have been followed.

  • Any substantive AI-assisted work has been appropriately disclosed.

  • Required supplementary documents have been attached.

  • The manuscript complies with journal formatting requirements.

Incomplete manuscripts or submissions that do not meet these requirements may be returned for technical correction before editorial evaluation.

26. Contact and Further Information

For journal information, manuscript submission, and editorial policies, authors should visit:

Indus Journal of Medical and Health Sciences (IJMHS)
Indus Education and Research Network SMC-Private Limited
DHA Valley (DHA Phase 7), Islamabad, Pakistan

Journal Website: https://induspublishers.com/index.php/IJMHS

Online Submission: https://induspublishers.com/index.php/IJMHS/about/submissions

Authors are encouraged to review the journal's current policies before preparing and submitting their manuscripts.